The global chemo graded nitrile powder-free medical examination gloves market size is expected to reach USD 611.6 million by 2030, expanding at 10.5% CAGR from 2023 to 2030. The market demand for chemo-graded nitrile powder-free medical examination gloves is likely to increase due to the rising incidence of cancer cases globally. Furthermore, according to WHO, cancer facilities accounted for almost 10 million fatalities in 2020, or roughly one in every six deaths, propelling projected market rise in the coming years.
According to the American Cancer Society, the population's expansion and aging are anticipated to cause 16.3 million cancer deaths and 27.5 million new cases of cancer worldwide by 2040. The burden is expected to increase in the future as a result of risk factors like smoking, eating poorly, being inactive, and having fewer pregnancies in developing countries. Over the projection period, the aforementioned reasons will fuel market demand.
With approximately 10 million recorded deaths from cancer in 2021, it is one of the top causes of death worldwide. In the same year, the WHO South-East Asia region recorded 1.4 million cancer-related fatalities and an estimated 2.2 million new cases, accounting for more than one in ten deaths in the region. Lung cancer caused 10.6% of all cancer-related deaths, followed by breast cancer (9.4%). Additionally, cervical cancer led to the deaths of 8% of patients, liver cancer of 6.6%, and cancer of the lips and mouth of 6.4% patients. In the upcoming years, rising cancer rates in the Asia-Pacific area will increase demand for chemo-graded, nitrile powder-free medical examination gloves.
The significance of early cancer diagnosis has increased as the number of cancer patients rises yearly. There is an increasing need for chemotherapy as a result of early detection and screening. The market will be driven in the future by this aspect. Owing to this demand, the major producers are focusing on creating excellent chemo-graded nitrile gloves. For instance, if evidence-based recommendations were fully implemented, ecancer.org predicts that between 2018 and 2040, the number of patient’s worldwide needing first-line chemotherapy treatment would increase from 9.8 million to 15 million. In turn, it is projected that over the projection period, demand for chemo-graded nitrile powder-free medical examination gloves would increase.
The demand for chemo-graded nitrile powder-free medical examination gloves is rising rapidly as the number of cancer patients is rising across the globe. Manufacturers are focused on launching new high-quality gloves. For instance, in March 2021, V12 Health launched a new product line of chemo-graded nitrile powder-free medical examination gloves and TPET gloves.
This product will be delivered within 1-3 business days.
According to the American Cancer Society, the population's expansion and aging are anticipated to cause 16.3 million cancer deaths and 27.5 million new cases of cancer worldwide by 2040. The burden is expected to increase in the future as a result of risk factors like smoking, eating poorly, being inactive, and having fewer pregnancies in developing countries. Over the projection period, the aforementioned reasons will fuel market demand.
With approximately 10 million recorded deaths from cancer in 2021, it is one of the top causes of death worldwide. In the same year, the WHO South-East Asia region recorded 1.4 million cancer-related fatalities and an estimated 2.2 million new cases, accounting for more than one in ten deaths in the region. Lung cancer caused 10.6% of all cancer-related deaths, followed by breast cancer (9.4%). Additionally, cervical cancer led to the deaths of 8% of patients, liver cancer of 6.6%, and cancer of the lips and mouth of 6.4% patients. In the upcoming years, rising cancer rates in the Asia-Pacific area will increase demand for chemo-graded, nitrile powder-free medical examination gloves.
The significance of early cancer diagnosis has increased as the number of cancer patients rises yearly. There is an increasing need for chemotherapy as a result of early detection and screening. The market will be driven in the future by this aspect. Owing to this demand, the major producers are focusing on creating excellent chemo-graded nitrile gloves. For instance, if evidence-based recommendations were fully implemented, ecancer.org predicts that between 2018 and 2040, the number of patient’s worldwide needing first-line chemotherapy treatment would increase from 9.8 million to 15 million. In turn, it is projected that over the projection period, demand for chemo-graded nitrile powder-free medical examination gloves would increase.
The demand for chemo-graded nitrile powder-free medical examination gloves is rising rapidly as the number of cancer patients is rising across the globe. Manufacturers are focused on launching new high-quality gloves. For instance, in March 2021, V12 Health launched a new product line of chemo-graded nitrile powder-free medical examination gloves and TPET gloves.
Chemo Graded Nitrile Powder-free Medical Examination Gloves Market Report Highlights
- The Asia Pacific accounted for a 42.5% market share of the market in 2022 owing to the high cancer prevalence and high mortality rate of the illness in the region. Considering the diverse, densely populated region of Southern, Eastern, and South-Eastern Asia, which is home to 4.2 billion people and hosts 55% of the world's population. 8.2 million new cancer cases and 5.2 million cancer deaths were predicted in the region in 2018, accounting for about half of the cancer burden globally, according to the American Cancer Society. China alone is responsible for 52% of the region's new cancer cases and 55% of its cancer fatalities
- India is anticipated to grow at a CAGR of 12.0% over the forecast period, as healthcare expenditure is expanding rapidly, resulting in the improved screening process and cancer treatment in India. For instance, according to the economic report of 2022, India's healthcare expenditure increased from 1.8% of GDP in 2020-2021 to 2.1% in 2021-2022
- Germany is expected to grow at a CAGR of 11.4% over the forecast period on account of the presence of advanced infrastructure & technology coupled with government support to revolutionize medical treatment. For instance, by linking pharmacies and hospitals via telematic infrastructures, digitizing healthcare administration, and incentivizing both telemedicine and telehealth activities, the Digitalization and Innovation (Digital Healthcare Act - DVG) integrates digital health into the healthcare landscape
- Manufacturers of chemo-graded nitrile powder-free medical examination gloves are focusing on rising production capacity by expanding their facilities or adopting several other strategies such as mergers & acquisitions, and product launches. For instance, in March 2020, Hartalega purchased land to expand its glove production facilities in Malaysia
- Furthermore, the market players are focusing expansion of business footprints globally. For instance, in December 2020, Ansell Ltd acquired the Primus brand to increase its presence in India
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope1.1. Research Methodology
1.2. Research Scope and Assumptions
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Competitive Insights
Chapter 3. Market Variables, Trends, and Scope
3.1. Market Lineage Outlook
3.2. Market Segmentation & Scope
3.3. Penetration & Growth Prospect Mapping
3.4. Industry Value Chain Analysis
3.4.1. Raw Material Outlook
3.4.2. Manufacturing & Technology Trends
3.5. Regulatory Framework
3.6. Chemo-graded Nitrile Powder-free Medical Examination Gloves Market - Market Dynamics
3.6.1. Market Driver Analysis
3.6.2. Market Restraint Analysis
3.6.3. Market Opportunity Analysis
3.7. Industry Analysis Tools: Chemo-graded Nitrile Powder-free Medical Examination Gloves Market
3.7.1. Porter’s Analysis
3.7.2. Macroeconomic Analysis
3.8. Economic Mega Trends Analysis
Chapter 4. Chemo-graded Nitrile Powder-free Medical Examination Gloves Market: Regional Estimates & Trend Analysis
4.1. Chemo-graded Nitrile Powder-free Medical Examination Gloves Market: Regional Movement Analysis, 2022 & 2030
4.2. North America
4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.2. U.S.
4.2.2.1. Macroeconomic Outlook
4.2.2.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.3. Canada
4.2.3.1. Macroeconomic Outlook
4.2.3.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.3. Europe
4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.2. Germany
4.3.2.1. Macroeconomic Outlook
4.3.2.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.3. U.K.
4.3.3.1. Macroeconomic Outlook
4.3.3.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.4. France
4.3.4.1. Macroeconomic Outlook
4.3.4.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.5. Russia
4.3.5.1. Macroeconomic Outlook
4.3.5.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.6. Italy
4.3.6.1. Macroeconomic Outlook
4.3.6.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.7. Spain
4.3.7.1. Macroeconomic Outlook
4.3.7.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.4. Asia Pacific
4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.2. China
4.4.2.1. Macroeconomic Outlook
4.4.2.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.3. Japan
4.4.3.1. Macroeconomic Outlook
4.4.3.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.4. India
4.4.4.1. Macroeconomic Outlook
4.4.4.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.5. South Korea
4.4.5.1. Macroeconomic Outlook
4.4.5.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.6. Australia
4.4.6.1. Macroeconomic Outlook
4.4.6.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.7. Indonesia
4.4.7.1. Macroeconomic Outlook
4.4.7.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Latin America
4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.2. Brazil
4.5.2.1. Macroeconomic Outlook
4.5.2.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3. Argentina
4.5.3.1. Macroeconomic Outlook
4.5.3.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.4. Mexico
4.5.4.1. Macroeconomic Outlook
4.5.4.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Middle East & Africa
4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.2. Saudi Arabia
4.6.2.1. Macroeconomic Outlook
4.6.2.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.3. UAE
4.6.3.1. Macroeconomic Outlook
4.6.3.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.4. South Africa
4.6.4.1. Macroeconomic Outlook
4.6.4.2. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Competitive Landscape
5.1. Recent Developments & Impact Analysis, By Key Market Participants
5.2. Company Categorization
5.3. Participant’s Overview
5.4. Financial Overview
5.5. Product Benchmarking
5.6. Company Market Positioning
5.7. Company Market Share Analysis
5.8. Company Heat Map Analysis
5.9. Strategy Mapping
Chapter 6. Company Profiles
6.1. Cardinal Health
6.2. Top Glove Corporation Bhd
6.3. Ansell Ltd.
6.4. Kimberly-Clark Corporation
6.5. Sempermed USA, Inc.
6.6. Health, Inc.
6.7. Tronex International, Inc.
6.8. McKesson Medical-Surgical Inc.
6.9. Hartalega Holdings Berhad
6.10. Safeko
List of Tables
Table 1. U.S. Macroeconomic Outlook
Table 2. Canada Macroeconomic Outlook
Table 3. Germany Macroeconomic Outlook
Table 4. France Macroeconomic Outlook
Table 5. Italy Macroeconomic Outlook
Table 6. Spain Macroeconomic Outlook
Table 7. U.K. Macroeconomic Outlook
Table 8. Russia Macroeconomic Outlook
Table 9. China Macroeconomic Outlook
Table 10. Japan Macroeconomic Outlook
Table 11. India Macroeconomic Outlook
Table 12. South Korea Macroeconomic Outlook
Table 13. Australia Macroeconomic Outlook
Table 14. Indonesia Macroeconomic Outlook
Table 15. Malaysia Macroeconomic Outlook
Table 16. Brazil Macroeconomic Outlook
Table 17. Argentina Macroeconomic Outlook
Table 18. Mexico Macroeconomic Outlook
Table 19. Saudi Arabia Macroeconomic Outlook
Table 20. UAE Macroeconomic Outlook
Table 21. South Africa Macroeconomic Outlook
Table 22. Recent Developments & Impact Analysis, By Key Market Participants
Table 23. Company Market Share, 2022
Table 24. Company Heat Map Analysis, 2022
Table 25. Key Companies undergoing expansion
Table 26. Key Companies involved in mergers & acquisition
List of Figures
Fig. 1 Market Segmentation & Scope
Fig. 2 Information Procurement
Fig. 3 Data Analysis Models
Fig. 4 Market Formulation And Validation
Fig. 5 Data Validating & Publishing
Fig. 6 Market Snapshot
Fig. 7 Segment Snapshot
Fig. 8 Competitive Landscape Snapshot
Fig. 9 Penetration and Growth Prospect Mapping
Fig. 10 Value Chain Analysis
Fig. 11 Market Dynamics
Fig. 12 Chemo-graded Nitrile Powder-free Medical Examination Gloves Market PORTER’s Analysis
Fig. 13 Chemo-graded Nitrile Powder-free Medical Examination Gloves Market PESTEL Analysis
Companies Mentioned
- Cardinal Health
- Top Glove Corporation Bhd
- Ansell Ltd.
- Kimberly-Clark Corporation
- Sempermed USA, Inc.
- Health, Inc.
- Tronex International, Inc.
- McKesson Medical-Surgical Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | March 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 274.7 Million |
| Forecasted Market Value ( USD | $ 611.6 Million |
| Compound Annual Growth Rate | 10.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
